If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

Share Price is delayed by 15 minutes
Get Live Data
27.50    0.00 (0.00%)
Bid:
27.00
Ask:
29.00
Spread: 2.00 (7.407%)
Market Cap: £13.34m
PEN Live PriceLast checked at - London Stock Exchange

Intraday Pennant International Share Chart

Directors incentivisation and Treasury Stock

8 Nov 2010 12:10

RNS Number : 7897V
Pennant International Group PLC
08 November 2010
 



PENNANT INTERNATIONAL GROUP PLC

(AIM: PEN)

 

Revised Incentive Arrangements for Executive Directors

 

Pennant International Group plc (the "Company") announces that following a review of the incentivisation arrangements for its executive directors, Chris Snook ("CS") and John Waller ("JW") it has undertaken the following measures (together the "Arrangements"):

·; the Company has established an employee benefit trust (the "EBT");

·; the Company has made an interest free loan of £292,775 to the EBT;

·; the Company has waived the performance conditions attached to share options held by CS and JW

·; the EBT has made interest free loans to CS and JW of £148,013 and £144,763 respectively;

·; each of CS and JW will apply the loan made to him to finance the acquisition from the Company of:

(1) 1,120,000 ordinary shares in the Company formerly held by the Company in Treasury, by exercising all their options to acquire shares in the Company for an aggregate exercise price of £188,050;

(2) 355,000 ordinary shares in the Company formerly held by the Company in Treasury, at a price of 14.75p per share;

·; the Company has cancelled 2,500,000 of its ordinary shares formerly held in Treasury.

 

Further details of and reasons for the Arrangements

The remuneration committee of the Company, Mr Christopher Powell and Mrs Jennifer Powell, consider that the Arrangements provide a better and more tax effective long term incentive to CS and JW to deliver value for shareholders than the former share option arrangements.

In place of the performance conditions attached to options held by CS and JW which have been waived in order to permit the options to be exercised, terms restricting the disposal of shares acquired by CS and JW have been included in the loans to them from the EBT. Prior to the announcement of the Company's results for its financial year ending 31 December 2012, in the event that CS or JW ceases to be an employee of the Company or any of its subsidiaries for any reason other than retirement due to ill-health or accident or a reason which gives rise to a claim by him for compensation for unfair dismissal, he must offer for sale to the EBT all shares in the Company acquired by him using the loan from the EBT at a sale price equal to the acquisition cost to him. Each of CS and JW will be obliged to repay the loan made to him by the EBT upon his ceasing to be an employee of the Company or any of its subsidiaries at any time. Upon the sale or disposal of any shares acquired by him using the loan from the EBT he will be obliged to repay a part of the loan equal to the acquisition cost to him of the shares so sold or disposed of. However, should the price of the shares acquired by CS and JW using loans from the EBT fall below the average cost per share at which he acquired them, he will be required to repay only so much of the loan as is equal to the market value of the shares held by him.

In accordance with the AIM Rules, the Arrangements constitute a related party transaction. The directors of the Company, other than CS and JW, consider, having consulted with the Company's nominated adviser, WH Ireland Limited, that the terms of the Arrangements are fair and reasonable in so far as its shareholders are concerned.

Following completion of the Arrangements, the interests of CS and JW in the ordinary voting share capital of the Company will be as follows:

 

Number of Ordinary Shares

Percentage of Voting Shares

Chris Snook

1,487,500

5.16

John Waller

1,829,097

6.35

 

Following completion of the Arrangements the Company will hold 693,123 ordinary shares in Treasury.

In accordance with the provisions of the Disclosure and Transparency Rules of the Financial Services Authority, the Company confirms that its issued share capital comprises 29,500,000 ordinary shares of 5p each. All of the ordinary shares have equal voting rights and 693,123 ordinary shares are held in Treasury. Therefore, the total number of voting rights in the Company is 28,806,877. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure and Transparency Rules.

 

 

Contacts:

 

Pennant International Group plc www.pennantplc.co.uk

Christopher Powell, Chairman +44 (0) 1452 714 881

John Waller, Finance Director

 

WH Ireland Limited www.wh-ireland.co.uk

Mike Coe / Marc Davies +44 (0) 117 945 3470

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSKKFDKBBDDODK
Date   Source Headline
24th Jun 20267:00 amRNS-RFirst Auxilium – GenS Sale via Siemens Partnership
12th Jun 20267:00 amRNSMultiyear Auxilium Services Contract Award
4th Jun 20267:00 amRNS-RLaunch of Auxilium Phase 3
20th May 20263:18 pmRNSHolding(s) in Company
19th May 20267:20 amRNS-R1st conversion services contract & Siemens update
14th May 20267:00 amRNSDirector dealing
13th May 20267:00 amRNSGrant of Options
11th May 20267:00 amRNSTraining Systems Contract Win
8th May 202611:56 amRNSResult of AGM
21st Apr 20262:05 pmRNSHolding(s) in Company
1st Apr 20262:54 pmRNSNotice of AGM & Posting of Accounts
31st Mar 20265:00 pmRNSTotal Voting Rights
26th Mar 20267:00 amRNSIssue of Equity
23rd Mar 20267:00 amRNSFinal Results & Notice of Investor Presentation
2nd Feb 20267:00 amRNSTraining Systems Contract Win
19th Jan 20267:00 amRNSTrading & Strategy Update, Notice of Results
15th Jan 20267:00 amRNSDirectorate change
12th Dec 20253:34 pmRNSDirector Dealing
1st Dec 20251:36 pmRNSDirector Dealing
27th Nov 20259:40 amRNSHolding(s) in Company
25th Nov 202512:40 pmRNSGenFly Contract Award - valued at up to £5.75m
24th Oct 202511:15 amRNSHolding(s) in Company
21st Oct 20257:00 amRNSShareholder Loan
8th Oct 202510:36 amRNSContract wins
1st Oct 20259:39 amRNSTotal Voting Rights
25th Sep 202512:59 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSSubscription update and closing & TVR
16th Sep 20257:01 amRNSProposed Underwritten Subscription to raise £1.25m
16th Sep 20257:00 amRNSInterim Results, Analyst Briefing & Investor Pres
14th Aug 20257:00 amRNSChange of Adviser
11th Aug 20253:01 pmRNSHolding(s) in Company
8th Aug 20257:00 amRNSTrading Update & Notice of Results
14th Jul 20257:00 amRNSGlobal Partner Appointed & Auxilium Presentation
3rd Jul 20257:00 amRNSBusiness Update
6th Jun 20251:08 pmRNSResult of AGM
8th May 202512:30 pmRNSNotice of AGM & Posting of Accounts
24th Apr 20257:00 amRNSFinal Results, Analyst Briefing & Investor Pres
9th Apr 20257:00 amRNSGenFly Contract Update
8th Apr 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
7th Apr 20257:00 amRNSProperty Disposal Programme Update
11th Mar 20252:25 pmRNSHolding(s) in Company
24th Feb 20257:00 amRNSProperty Disposal Programme Update
3rd Feb 20251:41 pmRNSDirector Dealings
16th Dec 202410:49 amRNSHolding(s) in Company
12th Dec 20247:00 amRNSAward of Options
10th Dec 20247:00 amRNSTrading Statement, Business Update & Investor Pres
20th Nov 20247:00 amRNSAppointment of CFO
14th Nov 20242:47 pmRNSHolding(s) in Company
6th Nov 20244:34 pmRNSHolding(s) in Company
23rd Oct 20243:56 pmRNSContracts Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.